Mental Health Clinics in Logan, OH Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Psychiatric Consultants, Llc Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1216 W Hunter St, Logan, OH 43138 Phone: 740-300-2080 Fax: 614-522-6604 |
Common Bond Counseling, Llc Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 1220 W Hunter St, Logan, OH 43138 Phone: 740-205-2999 Fax: 740-216-4501 |
Summit Recovery Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 549 E Front St, Logan, OH 43138 Phone: 740-279-9998 |
Hopewell Health Centers Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 541 State Route 664 N Ste C, Logan, OH 43138 Phone: 740-385-6594 Fax: 740-380-3750 |
News Archive
Malawi in need of food aid increase, WFP warns
"About 1.6 million Malawians will need food aid before this year's harvest, an eightfold increase from last year, because of poor crops and rising prices, the United Nations World Food Programme [WFP] said," Bloomberg Businessweek reports.
FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system
Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.
Segregating household sleeping arrangements can help prevent malaria spread
Better malaria control might come from segregating household sleeping arrangements, according to a new study co-authored by a University of Guelph professor.
CRI, Oncovir sign new investment agreement to produce immunological stimulant
Cancer Research Institute, a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund, a joint initiative with the Ludwig Institute for Cancer Research, has completed a new investment agreement with Oncovir, a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol- (Poly-ICLC).
› Verified 4 days ago